9 withdrawn. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Withdrawn 9 |
Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hormone Secretion in Transgender Males Testosterone Cyp 200Mg/Ml Inj (in Oil), Letrozole - Transgender, Healthy | Phase 4 | Withdrawn | University of California, San Diego | 2023-07-01 | 2025-01-13 | |
| Direct Measurement of Proinsulin Clearance in Humans Somatostatin - Healthy | Phase 4 | Withdrawn | Mayo Clinic | 2022-11-01 | 2022-12-15 | |
| A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions Cymbalta capsule, Duloxetine hydrochloride capsule - Healthy | Phase 4 | Withdrawn | Pfizer | 2020-03-30 | 2019-09-27 | |
| A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Cymbalta Capsules, Duloxetine Hydrochloride Capsules - Healthy | Phase 4 | Withdrawn | Pfizer | 2020-03-30 | 2019-10-04 | |
| Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion Somatostatin, Dextrose, Insulin - Healthy | Phase 4 | Withdrawn | Mayo Clinic | 2020-02-01 | 2022-09-09 | |
| Effect of Simvastatin Withdrawal on Ocular Endothelial Function Dynamic Vessel Analyzer (DVA), Laser Doppler Velocimetry (LDV), Simvastatin - Healthy | Phase 4 | Withdrawn | Medical University of Vienna | 2019-10-01 | 2020-02-20 | |
| The Influence of Exercise and Hydration to the Pharmacological Response to Inhaled Terbutalin and Salbutamol in Men Exercise - Healthy | Phase 4 | Withdrawn | Vibeke Backer | 2013-11-01 | 2023-03-01 | |
| A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel Rapydan, tetracaine gel - Healthy, Anesthesia | Phase 4 | Withdrawn | Jazz Pharmaceuticals | 2008-04-01 | 2012-04-25 | |
| Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem eszopiclone, zolpidem, placebo - Healthy | Phase 4 | Withdrawn | Kettering Health Network | 2016-02-26 |
Dehydration (1) · Motor Activity (1)
Behavior (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Water-Electrolyte Imbalance (1)
Drug Evaluation (2) · Duloxetine Hydrochloride (2) · Somatostatin (2) · Eszopiclone (1) · Exercise (1) · Glucose (1) · Glucose Clamp Technique (1) · Insulin (1) · Laser-Doppler Flowmetry (1) · Letrozole (1) · Simvastatin (1) · Zolpidem (1) · soybean oil, phospholipid emulsion (1) · testosterone 17 beta-cypionate (1)
Mayo Clinic (2) · Pfizer (2) · Jazz Pharmaceuticals (1) · Kettering Health Network (1) · Medical University of Vienna (1) · University of California, San Diego (1) · Vibeke Backer (1)
United States (3) · Austria (1) · Denmark (1) · United Kingdom (1)
Adrian Vella (1) · Adrian Vella, MD (1) · Joseph C Mantil, MD, PhD (1) · Rahul Dimber, MD (1) · Vibeke Backer, Professor (1)
R01DK078645 (1), R01DK078646 (1)